Skip to Content

FML-S Dosage

Generic name: fluorometholone and sulfacetamide sodium
Dosage form: Ophthalmic Suspension

Medically reviewed on February 20, 2018.

One drop of FML-S® ophthalmic suspension should be instilled into the conjunctival sac four times daily. Care should be taken not to discontinue therapy prematurely. If signs and symptoms fail to improve after two days, the patient should be re-evaluated (see PRECAUTIONS).

The dosing of FML-S® ophthalmic suspension may be reduced, but care should be taken not to discontinue therapy prematurely. In chronic conditions, withdrawal of treatment should be carried out by gradually decreasing the frequency of applications.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

More about FML-S (fluorometholone / sulfacetamide sodium ophthalmic)

Professional resources

Other Formulations

Related treatment guides

Hide